In 2026, China's pharmaceutical export sector is poised for significant expansion, building on 2025's record-breaking out-licensing deals and a surge in innovative therapies. As the world's ...

India aims to expand its pharmaceutical export presence beyond largest market of United States U.S. accounts for about a third of India's total pharmaceutical exports Potential to increase exports to ...

West Asia–North Africa represented $1.75 billion of India’s FY25 pharma exports, dominated by finished dosage forms plus biosimilars and vaccines, with the UAE, Iraq, Egypt, and Saudi Arabia leading.

India’s pharmaceutical exports continued to expand in 2024–25, rising 9.4 percent to $30.47 billion, reflecting the sector’s ...

NEW DELHI: iPHEX 2025 – 11th Edition of International Exhibition and Healthcare, is scheduled from September 4–6, 2025, at Bharat Mandapam, New Delhi. Organized by the Pharmexcil (Pharmaceuticals ...

India can further consolidate its positioning in global pharmaceutical markets as a “trusted” supplier of affordable, quality medicines by overcoming non-trade barriers, expanding regulatory ...

Trade unpredictability exposes vulnerabilities in the pharmaceutical supply chain that must be addressed to build resilient systems ensuring patient access despite geopolitical challenges.

In the United States export control laws and regulations require companies to receive export licenses prior to releasing any controlled items or technologies to non-U.S. persons. The process of ...